These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8241141)

  • 1. Structure of the protease from simian immunodeficiency virus: complex with an irreversible nonpeptide inhibitor.
    Rose RB; Rosé JR; Salto R; Craik CS; Stroud RM
    Biochemistry; 1993 Nov; 32(46):12498-507. PubMed ID: 8241141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors.
    Zhao B; Winborne E; Minnich MD; Culp JS; Debouck C; Abdel-Meguid SS
    Biochemistry; 1993 Dec; 32(48):13054-60. PubMed ID: 8241159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of nonpeptide irreversible inhibitors of HIV proteases.
    Salto R; Babé LM; Li J; Rosé JR; Yu Z; Burlingame A; De Voss JJ; Sui Z; Ortiz de Montellano P; Craik CS
    J Biol Chem; 1994 Apr; 269(14):10691-8. PubMed ID: 8144659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkylation of a catalytic aspartate group of the SIV protease by an epoxide inhibitor.
    Caldera PS; Yu Z; Knegtel RM; McPhee F; Burlingame AL; Craik CS; Kuntz ID; Ortiz de Montellano PR
    Bioorg Med Chem; 1997 Nov; 5(11):2019-27. PubMed ID: 9416419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
    Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
    Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
    Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human immunodeficiency virus 1 protease expressed in Escherichia coli behaves as a dimeric aspartic protease.
    Meek TD; Dayton BD; Metcalf BW; Dreyer GB; Strickler JE; Gorniak JG; Rosenberg M; Moore ML; Magaard VW; Debouck C
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):1841-5. PubMed ID: 2648384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyr115, gln165 and trp209 contribute to the 1, 2-epoxy-3-(p-nitrophenoxy)propane-conjugating activity of glutathione S-transferase cGSTM1-1.
    Chern MK; Wu TC; Hsieh CH; Chou CC; Liu LF; Kuan IC; Yeh YH; Hsiao CD; Tam MF
    J Mol Biol; 2000 Jul; 300(5):1257-69. PubMed ID: 10903867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of protein unfolding studies to determine the conformational and dimeric stabilities of HIV-1 and SIV proteases.
    Grant SK; Deckman IC; Culp JS; Minnich MD; Brooks IS; Hensley P; Debouck C; Meek TD
    Biochemistry; 1992 Oct; 31(39):9491-501. PubMed ID: 1390732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative native flap conformation revealed by 2.3 A resolution structure of SIV proteinase.
    Wilderspin AF; Sugrue RJ
    J Mol Biol; 1994 May; 239(1):97-103. PubMed ID: 8196050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus protease ligand specificity conferred by residues outside of the active site cavity.
    Hoog SS; Towler EM; Zhao B; Doyle ML; Debouck C; Abdel-Meguid SS
    Biochemistry; 1996 Aug; 35(32):10279-86. PubMed ID: 8756683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray analyses of aspartic proteinases. III Three-dimensional structure of endothiapepsin complexed with a transition-state isostere inhibitor of renin at 1.6 A resolution.
    Veerapandian B; Cooper JB; Sali A; Blundell TL
    J Mol Biol; 1990 Dec; 216(4):1017-29. PubMed ID: 2266553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of equine infectious anemia virus proteinase complexed with an inhibitor.
    Gustchina A; Kervinen J; Powell DJ; Zdanov A; Kay J; Wlodawer A
    Protein Sci; 1996 Aug; 5(8):1453-65. PubMed ID: 8844837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Domain flexibility in retroviral proteases: structural implications for drug resistant mutations.
    Rose RB; Craik CS; Stroud RM
    Biochemistry; 1998 Feb; 37(8):2607-21. PubMed ID: 9485411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and amino acid sequence of a peptide containing an epoxide-reactive residue from the thermolysin-digest of Scytalidium lignicolum acid protease B.
    Tsuru D; Shimada S; Maruta S; Yoshimoto T; Oda K; Murao S; Miyata T; Iwanaga S
    J Biochem; 1986 May; 99(5):1537-9. PubMed ID: 3519605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structures of HIV-1 and SIV protease product complexes.
    Rose RB; Craik CS; Douglas NL; Stroud RM
    Biochemistry; 1996 Oct; 35(39):12933-44. PubMed ID: 8841139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor.
    Laco GS; Schalk-Hihi C; Lubkowski J; Morris G; Zdanov A; Olson A; Elder JH; Wlodawer A; Gustchina A
    Biochemistry; 1997 Sep; 36(35):10696-708. PubMed ID: 9271500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization and preliminary X-ray investigation of recombinant simian immunodeficiency virus proteinase.
    Wilderspin AF; Sugrue RJ
    J Mol Biol; 1993 Jun; 231(4):1139-42. PubMed ID: 8515473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray structure of simian immunodeficiency virus integrase containing the core and C-terminal domain (residues 50-293)--an initial glance of the viral DNA binding platform.
    Chen Z; Yan Y; Munshi S; Li Y; Zugay-Murphy J; Xu B; Witmer M; Felock P; Wolfe A; Sardana V; Emini EA; Hazuda D; Kuo LC
    J Mol Biol; 2000 Feb; 296(2):521-33. PubMed ID: 10669606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the S1/S1' substrate binding pocket geometry of HIV-1 protease with modified aspartic acid analogues.
    Short GF; Laikhter AL; Lodder M; Shayo Y; Arslan T; Hecht SM
    Biochemistry; 2000 Aug; 39(30):8768-81. PubMed ID: 10913288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.